Background Long‐acting injectable cabotegravir (CAB‐LA) represents a new additional
option for HIV prevention in people at substantial risk of HIV infection that may fill the gaps in …

Introduction Several low‐and middle‐income countries (LMICs) are preparing to introduce
long‐acting pre‐exposure prophylaxis (LAP). Amid multiple pre‐exposure prophylaxis …

Introduction Oral pre‐exposure prophylaxis (PrEP) has the potential to reduce HIV
acquisition among adolescent girls and young women (AGYW) in sub‐Saharan Africa, a …

Background Adolescent girls and young women (AGYW) account for 29% of new HIV
infections in Uganda despite representing just 10% of the population. Peer support improves …

Introduction Pre-exposure prophylaxis (PrEP) is a highly effective HIV prevention strategy
and is recommended for populations at risk of HIV, including adolescent girls and young …

Background Adolescent girls and young women accounted for 25% of all new HIV infections
despite representing only 10% of the population in Sub Saharan Africa. PEPFAR has …

Out-of-school adolescent girls/young women (AGYW) in Africa are at increased risk for HIV
and are underserved by HIV prevention interventions. Identifying social networks of out-of …

Introduction Some African countries plan to introduce and scale-up new long-acting pre-
exposure prophylaxis methods (LA-PrEP), like the monthly dapivirine vaginal ring (PrEP …

Abstract Purpose of Review Despite highly effective biomedical HIV pre-exposure
prophylaxis (PrEP) options, suboptimal PrEP uptake impedes progress towards ending the …

In the scaling up of HIV prevention for AGYW, implementers are encouraged to consider
both PrEP products and PrEP delivery outlet preferences. Understanding and responding to …